ÎåÐÇÌåÓýÖ±²¥ was Founded in 2002 with the Goal of Engineering Exquisite Enzymes for a Variety of Industries and Applications
Today, we are a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing by leveraging our proprietary CodeEvolver® technology platform to discover, develop and enhance novel, high-performance enzymes and other classes of proteins.
We’ve engineered the enzymes that have enabled some of the biggest pharmaceutical products ever developed, including Januvia (sitagliptin), Lipitor (atorvastatin) and Paxlovid (nirmatrelvir). Our work has been recognized with multiple Green Chemistry Challenge Awards from the American Chemical Society and we are known for our platform’s proven ability to revolutionize enzyme performance by increasing activity, specificity, and stability. Building upon this legacy, today we are focused on applying our deep expertise to the enzymatic manufacturing of small interference ribonucleic acid (siRNA) therapeutics.